Screener
BioMarin Pharmaceuticals BMRN Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's asset turnover?
- BioMarin Pharmaceuticals (BMRN) reported asset turnover of 0.4× in Q2 2026.
- How has BioMarin Pharmaceuticals's asset turnover changed year-over-year?
- BioMarin Pharmaceuticals's asset turnover decreased by 15.8% year-over-year, from 0.4× to 0.4×.
- What is the long-term trend for BioMarin Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's asset turnover has grown at a 4.6% compound annual growth rate (CAGR), from 0.4× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about BioMarin Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude